DRMA 8-K: SEC filing

Dermata Therapeutics

Filed with the SEC on Nov 10, 2026 · accession 0001493152-26-050964

DRMA filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -6.4% by the first close after the filing.

Summary of the filing

Dermata Therapeutics issued a press release reporting its financial results for the third quarter ended September 30, 2026, and provided a corporate update.

For details, click here →How to read a 8-K →

Key details

RegistrantDermata Therapeutics, Inc.

President, chairman and chief executive officerGerald T. Proehl

How DRMA stock reacted

Close before

$0.77

Nov 9, 2026

First close after

-6.36%

$0.72

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for DRMA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DRMA?

Click here

Frequently asked questions

What did DRMA file with the SEC on Nov 10, 2026?

DRMA filed a 8-K (SEC filing). Dermata Therapeutics issued a press release reporting its financial results for the third quarter ended September 30, 2026, and provided a corporate update.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did DRMA stock react to this filing?

DRMA closed at $0.77 before the filing and $0.72 on Nov 10, 2026 (-6.36%).

Other DRMA SEC filings

Get alerts when DRMA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

DRMA overview DRMA analysis DRMA news Latest SEC filings